Chang Lu

1.3k total citations
54 papers, 768 citations indexed

About

Chang Lu is a scholar working on Surgery, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Chang Lu has authored 54 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 18 papers in Molecular Biology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Chang Lu's work include Spine and Intervertebral Disc Pathology (13 papers), Spinal Fractures and Fixation Techniques (13 papers) and Cancer-related molecular mechanisms research (6 papers). Chang Lu is often cited by papers focused on Spine and Intervertebral Disc Pathology (13 papers), Spinal Fractures and Fixation Techniques (13 papers) and Cancer-related molecular mechanisms research (6 papers). Chang Lu collaborates with scholars based in China, United States and Denmark. Chang Lu's co-authors include Jing Li, Xiaobin Wang, Qin Dai, Guohua Lü, Bing Wang, Qianshi Zhang, Youwen Deng, Yijun Kang, Guohua Lv and Min Xu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, ACS Applied Materials & Interfaces and Gene.

In The Last Decade

Chang Lu

52 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Lu China 17 288 258 199 103 67 54 768
Mehmet Şahin Türkiye 18 132 0.5× 221 0.9× 133 0.7× 61 0.6× 52 0.8× 62 872
Yang Dezhai China 21 367 1.3× 317 1.2× 100 0.5× 133 1.3× 142 2.1× 49 1.1k
Ru-Chun Dai China 17 139 0.5× 499 1.9× 88 0.4× 205 2.0× 48 0.7× 49 1.0k
Daoliang Xu China 10 126 0.4× 250 1.0× 305 1.5× 62 0.6× 54 0.8× 13 668
Yun Zhou China 14 148 0.5× 286 1.1× 58 0.3× 103 1.0× 56 0.8× 66 669
Yunfeng Zhang China 17 220 0.8× 237 0.9× 53 0.3× 60 0.6× 119 1.8× 86 854
Luwei Xiao China 19 265 0.9× 341 1.3× 69 0.3× 52 0.5× 43 0.6× 59 904
Xuezhi Zhang China 16 185 0.6× 199 0.8× 50 0.3× 72 0.7× 91 1.4× 58 651

Countries citing papers authored by Chang Lu

Since Specialization
Citations

This map shows the geographic impact of Chang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Lu more than expected).

Fields of papers citing papers by Chang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Lu. The network helps show where Chang Lu may publish in the future.

Co-authorship network of co-authors of Chang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Lu. A scholar is included among the top collaborators of Chang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Lu. Chang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yu, Nan Wei, Chang Lu, et al.. (2025). Mechanistic insights into honey-boiled detoxification of ChuanWu: A study on alkaloid transformation and supramolecular aggregation. Journal of Pharmaceutical Analysis. 15(9). 101205–101205. 1 indexed citations
3.
Deng, Xuan, Chang Lu, Ling‐Yu Tang, et al.. (2025). Long noncoding RNA GDIL acts as a scaffold for CHAC1 and XRN2 to promote platinum resistance of colorectal cancer through inhibition of glutathione degradation. Cell Death and Disease. 16(1). 62–62. 6 indexed citations
4.
Lu, Chang, Chao Qin, Qianqian Xu, et al.. (2025). The crosstalk between glutathione metabolism and non-coding RNAs in cancer progression and treatment resistance. Redox Biology. 84. 103689–103689. 3 indexed citations
5.
Liu, Heng, Xiaotong Li, Dandan Song, et al.. (2024). Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model. International Journal of Nanomedicine. Volume 19. 1205–1224. 16 indexed citations
6.
Zhou, Xin‐Fu, Leo Wang, Ying Xiong, et al.. (2023). A single dose of ketamine relieves fentanyl-induced-hyperalgesia by reducing inflammation initiated by the TLR4/NF-κB pathway in rat spinal cord neurons. Drug Discoveries & Therapeutics. 17(4). 279–288. 2 indexed citations
7.
Yu, Wei, et al.. (2022). Pharmacological Mechanism of Pingxiao Formula against Colorectal Cancer. Evidence-based Complementary and Alternative Medicine. 2022. 1–17. 2 indexed citations
8.
Yan, Jing, Wei Yu, Guoliang Wang, et al.. (2022). LRRK2 deficiency mitigates colitis progression by favoring resolution of inflammation and restoring homeostasis of gut microbiota. Genomics. 114(6). 110527–110527. 12 indexed citations
9.
Yu, Wei, Zhiqiang Zhang, Chen Liu, et al.. (2022). The Wu-Shi-Cha formula protects against ulcerative colitis by orchestrating immunity and microbiota homeostasis. Journal of Ethnopharmacology. 304. 116075–116075. 1 indexed citations
10.
Lu, Chang, et al.. (2021). DUSP1 overexpression attenuates renal tubular mitochondrial dysfunction by restoring Parkin-mediated mitophagy in diabetic nephropathy. Biochemical and Biophysical Research Communications. 559. 141–147. 19 indexed citations
11.
Yan, Jing, Wei Yu, Chang Lu, et al.. (2021). The Pharmacological Mechanism of Guchangzhixie Capsule Against Experimental Colitis. Frontiers in Pharmacology. 12. 762603–762603. 6 indexed citations
12.
Lu, Chang, et al.. (2021). LINC00176 facilitates CD4+T cell adhesion in systemic lupus erythematosus via the WNT5a signaling pathway by regulating WIF1. Molecular Immunology. 134. 202–209. 9 indexed citations
13.
Wu, Junjie, et al.. (2020). Igf2bp1 is required for hepatic outgrowth during early liver development in zebrafish. Gene. 744. 144632–144632. 13 indexed citations
14.
Li, Hongyan, et al.. (2018). NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy. Cellular Physiology and Biochemistry. 48(4). 1675–1693. 50 indexed citations
15.
Lu, Chang, et al.. (2018). Role of spinal cyclooxygenase-2 and prostaglandin E2 in fentanyl-induced hyperalgesia in rats. British Journal of Anaesthesia. 120(4). 827–835. 17 indexed citations
17.
Wang, Xiaobin, Guohua Lv, Jing Li, et al.. (2017). LncRNA‐RP11‐296A18.3/miR‐138/HIF1A Pathway Regulates the Proliferation ECM Synthesis of Human Nucleus Pulposus Cells (HNPCs). Journal of Cellular Biochemistry. 118(12). 4862–4871. 54 indexed citations
18.
Lu, Chang, Junjie Wu, Shuting Xiong, et al.. (2017). MicroRNA-203a regulates fast muscle differentiation by targeting dmrt2a in zebrafish embryos. Gene. 625. 49–54. 22 indexed citations
19.
Lu, Chang, et al.. (2010). Surgical treatment of cervical kyphosis. European Spine Journal. 20(4). 523–536. 66 indexed citations
20.
Li, Jing, Guohua Lv, Xiaobin Wang, Bing Wang, & Chang Lu. (2010). Delayed paraplegia following correction of severe thoracolumbar kyphotic deformity by posterior vertebral column resection. Orthopaedic Surgery. 2(1). 71–76. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026